
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
Junqing Gan, Shan Liu, Yu Zhang, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 8, pp. 1290-1305
Open Access | Times Cited: 35
Junqing Gan, Shan Liu, Yu Zhang, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 8, pp. 1290-1305
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 59
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 59
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24
Prostate cancer epigenetics — from pathophysiology to clinical application
Vera Constâncio, João Lobo, José Pedro Sequeira, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Vera Constâncio, João Lobo, José Pedro Sequeira, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma
Qiangsheng Wang, Qiqin Shi, Zhenqian Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Qiangsheng Wang, Qiqin Shi, Zhenqian Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
PVT1 inhibition stimulates anti-tumor immunity, prevents metastasis, and depletes cancer stem cells in squamous cell carcinoma
Zhen Qin, Wen‐Bo Zhang, Shuo Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 14
Zhen Qin, Wen‐Bo Zhang, Shuo Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 14
Small extracellular vesicles: crucial mediators for prostate cancer
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer
Saravanan Ramesh, Preethi Selvakumar, Mohamed Yazeer Ameer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Saravanan Ramesh, Preethi Selvakumar, Mohamed Yazeer Ameer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Non-coding RNAs’ function in cancer development, diagnosis and therapy
Xinyi Zhang, Xiaoqing Xu, Jiajia Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115527-115527
Open Access | Times Cited: 11
Xinyi Zhang, Xiaoqing Xu, Jiajia Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115527-115527
Open Access | Times Cited: 11
Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis
Yuliang Zhou, Wenliang Yao, Shenghui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Yuliang Zhou, Wenliang Yao, Shenghui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Mirna Based Liquid Biopsy for Castration-Resistant Prostate Cancer Diagnostics
E.V. Shutko, Maria Konoshenko, Milena Saitkulova, et al.
(2025)
Closed Access
E.V. Shutko, Maria Konoshenko, Milena Saitkulova, et al.
(2025)
Closed Access
Harnessing the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Prostate Cancer: Current Insight and Perspective
Mafewu Olga Raboshakga, Anh Duy, Ida Kurniawati, et al.
IntechOpen eBooks (2025)
Closed Access
Mafewu Olga Raboshakga, Anh Duy, Ida Kurniawati, et al.
IntechOpen eBooks (2025)
Closed Access
Yanming Hu, Jin Zhou, Xinru Ling, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Prostate cancer and microRNAs: New insights into apoptosis
Jitendra Gupta, Waleed K. Abdulsahib, Abduladheem Turki Jalil, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154436-154436
Closed Access | Times Cited: 10
Jitendra Gupta, Waleed K. Abdulsahib, Abduladheem Turki Jalil, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154436-154436
Closed Access | Times Cited: 10
miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy
Arsinoe C. Thomaidou, Maria Goulielmaki, Antonis Tsintarakis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9189-9189
Open Access | Times Cited: 9
Arsinoe C. Thomaidou, Maria Goulielmaki, Antonis Tsintarakis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9189-9189
Open Access | Times Cited: 9
Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers
Jaya Aseervatham
Biology (2023) Vol. 12, Iss. 5, pp. 710-710
Open Access | Times Cited: 9
Jaya Aseervatham
Biology (2023) Vol. 12, Iss. 5, pp. 710-710
Open Access | Times Cited: 9
An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer
Mengjie Chen, Cheng Zou, Yu Tian, et al.
Oncogene (2024) Vol. 43, Iss. 21, pp. 1594-1607
Closed Access | Times Cited: 3
Mengjie Chen, Cheng Zou, Yu Tian, et al.
Oncogene (2024) Vol. 43, Iss. 21, pp. 1594-1607
Closed Access | Times Cited: 3
Prostate cancer and the cell cycle: Focusing on the role of microRNAs
Ibrahim M. Elazab, Ola A. El-Feky, Eman G. Khedr, et al.
Gene (2024) Vol. 928, pp. 148785-148785
Closed Access | Times Cited: 3
Ibrahim M. Elazab, Ola A. El-Feky, Eman G. Khedr, et al.
Gene (2024) Vol. 928, pp. 148785-148785
Closed Access | Times Cited: 3
MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes
Suzana Matijašević Joković, Zorana Dobrijević, Nevena Kotarac, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2320-2320
Open Access | Times Cited: 15
Suzana Matijašević Joković, Zorana Dobrijević, Nevena Kotarac, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2320-2320
Open Access | Times Cited: 15
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity
Chan Shan, Yan Liang, Kun Wang, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 347-366
Open Access | Times Cited: 8
Chan Shan, Yan Liang, Kun Wang, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 347-366
Open Access | Times Cited: 8
Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression
Wei Jiang, Guosheng Gu, Yumin Zhang, et al.
Pharmacological Research (2023) Vol. 197, pp. 106942-106942
Open Access | Times Cited: 7
Wei Jiang, Guosheng Gu, Yumin Zhang, et al.
Pharmacological Research (2023) Vol. 197, pp. 106942-106942
Open Access | Times Cited: 7
Beyond the genome: MALAT1's role in advancing urologic cancer care
Mohd Imran, Abida Khan, Lina Eltaib, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155226-155226
Closed Access | Times Cited: 2
Mohd Imran, Abida Khan, Lina Eltaib, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155226-155226
Closed Access | Times Cited: 2
Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy
Tingting Yang, Nan Zhang, Yuanyuan Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Tingting Yang, Nan Zhang, Yuanyuan Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation
Junqing Gan, Yu Zhang, Shan Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Junqing Gan, Yu Zhang, Shan Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Research of the unrecognised functions of miR-375 in prostate cancer cells
Merve Goztepe, Onur Eroğlu
Cellular and Molecular Biology (2024) Vol. 70, Iss. 3, pp. 212-218
Open Access | Times Cited: 1
Merve Goztepe, Onur Eroğlu
Cellular and Molecular Biology (2024) Vol. 70, Iss. 3, pp. 212-218
Open Access | Times Cited: 1
Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer
Chin‐Chou Wang, Wan‐Jou Shen, Gangga Anuraga, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1947-1947
Open Access | Times Cited: 7
Chin‐Chou Wang, Wan‐Jou Shen, Gangga Anuraga, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1947-1947
Open Access | Times Cited: 7